Proton beam therapy for the treatment of prostate cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24674325.
- Also identified by DOI 10.1016/j.prro.2012.05.010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Proton beam therapy (PBT) offers the potential of dose escalation to target tissue while decreasing toxicity through unique physical dose deposition characteristics. PBT has been used to treat prostate cancer for several decades; however, recent enhancements in availability and treatment delivery have peaked interest in this technology among radiation oncologists, industry experts, and prostate cancer patients. As a result, the importance of understanding the collective experience and technical aspects of PBT delivery has become increasingly important in radiation medicine. This review article is intended to critically review the literature on PBT for localized prostate cancer, discuss the fundamentals of PBT treatment planning, and describe the continued development of proton beam technology for the treatment of prostate cancer.